Richter BioLogics is a leading Contract Development and Manufacturing Organisation (CDMO) specialising in microbial-derived biopharmaceuticals. With over 35 years of expertise, the company operates two cGMP-compliant facilities in Germany, focusing on flexible and efficient production for global clients.

Key Products and Services

• Development and manufacturing of plasmid DNA, recombinant proteins, and bacterial vaccines.
• Strain and process development for microbial systems.
• Analytical testing and quality control meeting EMA, FDA, and global standards.
• Production capacities from 10L to 1500L.

By combining innovation with regulatory excellence, Richter BioLogics supports biopharma advancements worldwide. For more, visit Richter BioLogics.